Researchers use firefly protein to visualize cellular communication pathways in mice, revealing potential for non-invasive cancer treatment and disease research. This breakthrough enables scientists to watch proteins in their natural setting, improving understanding of human diseases.
A new DNA vaccine has entered human trials, incorporating parts of four HIV genes to target various subtypes. The trial aims to determine the vaccine's safety and immune response, with expanded tests planned for international sites.
Researchers at Rutgers-Newark are using electrical imaging to monitor the performance of permeable reactive barriers, which remove contaminants from groundwater. The study aims to improve the understanding of iron wall impacts and develop a tool for long-term monitoring of underground technologies.
Researchers develop technology to characterize unknown bacteria, helping astronauts stay healthy in space. The system predicts bacteria's source and identifies potential infection risks.
A study by Syracuse University researchers found that the frequency of El Niño events peaked around 1,200 years ago and may increase in the early part of the 22nd century. The 2,000-year cycle could have a significant impact on global climate conditions.
A University of Massachusetts Amherst study reveals that microorganisms in Boston Harbor sediments can break down PAHs using sulfate, potentially reducing the need for expensive remediation strategies. The findings suggest that natural activity can clean up contaminated harbors without active environmental protection.
A study published in Nature found that changes in the North Atlantic Oscillation synchronize population fluctuations of caribou and muskoxen across Greenland. The researchers used local and global weather data to show cross-species synchrony, indicating the North Atlantic Oscillation's influence on their population dynamics.
Researchers have developed a sepsis vaccine that provides outstanding protection by reducing inflammatory chemicals by nearly 95%. The vaccine targets endotoxins, which trigger the immune system's response to infection.
The 2002 AAAS Science Journalism Award recipients were honored for their exemplary communications efforts on various topics including climate change, marine reserves, and reproductive technologies. The award recipients will each receive a $2,500 cash award and plaque during the 2003 AAAS Annual Meeting in Denver.
Acorda Therapeutics has received the L.W. Freeman Award for its pioneering work in regenerative therapies and functional improvements for spinal cord injury patients. The company's lead product, Fampridine-SR, is in Phase 3 clinical trials for chronic SCI and aims to restore function in people with SCI.
Physicist Bryan Caron and his team have achieved a world record-breaking data transfer rate, equivalent to transferring a full compact disk in under eight seconds. The team created a dedicated 'light path' spanning 12,000 km, bypassing the public Internet to establish a new transatlantic superhighway for researchers.
A recent study found that high levels of cyclin E are closely associated with aggressive breast cancer, making it a powerful predictive marker. The presence of low molecular weight forms of cyclin E also showed strong prognostic value, indicating a higher risk of recurrence and spread.
A nationwide survey of adoption agencies found that 63% of respondents accepted applications from homosexual individuals, with nearly 38% having made at least one adoption. Key factors impacting willingness included religious affiliation and the type of children placed.
Researchers aim to enhance understanding of artificial and natural knee joint failures, improve surgical procedures, and create longer-lasting implants. They are developing computational wear models that make quantifiable predictions of deterioration, enabling surgeons to select individualized knee designs.